Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Janssen

Showing results (181-190 of 579) with videos related to

Pageof 58
Sort By:
British Journal of Cancer|October 1, 1989
Serum C1-esterase inhibitor, an essential and independent prognosticator of gastric carcinomaC W Janssen, R T Lie, H Maartmann-Moe, et al.
Zookeys|November 11, 2016
Revision of the genus <i>Cuvierina</i> Boas, 1886 based on integrative taxonomic data, including the description of a new species from the Pacific Ocean (Gastropoda, Thecosomata)Alice K Burridge, Arie W Janssen, Katja T C A Peijnenburg
Leukemia|July 1, 1993
Mutations within the FLR exon of NF1 are rare in myelodysplastic syndromes and acute myelocytic leukemiasL Ludwig, J W Janssen, A S Schulz, et al.
Oncogene|May 15, 1998
An oncogenic fusion product of the phosphatidylinositol 3-kinase p85beta subunit and HUMORF8, a putative deubiquitinating enzymeJ W Janssen, L Schleithoff, C R Bartram, et al.
British Journal of Cancer|April 1, 1991
The influence of age on the growth and spread of gastric carcinomaC W Janssen, R T Lie, H Maartmann-Moe, et al.
Clinical Chemistry|February 1, 2023
Abdominal Pain and Cola-Colored SerumWouter M Tiel Groenestege, Ella J Wijnen, Marcel J W Janssen
Current Opinion in Urology|November 14, 2023
Restoring the barrier of chronically damaged urothelium using chondroitin sulfate glycosaminoglycan-replenishment therapyBoy B Rozenberg, Charlotte J van Ginkel, Dick A W Janssen
Deutsche Medizinische Wochenschrift (1946)|September 1, 2009
[Update: Preclinical developments for the treatment of pulmonary arterial hypertension]W Janssen, H A Ghofrani, N Weissmann, et al.
Leukemia|March 17, 2000
Tandem duplication of the FLT3 gene in acute lymphoblastic leukemia: a marker for the monitoring of minimal residual diseaseM Nakao, J W Janssen, D Erz, et al.
Blood|June 1, 1988
Mutation of Ki-ras and N-ras oncogenes in myelodysplastic syndromesJ Lyons, J W Janssen, C Bartram, et al.
Pageof 58

Showing results (181-190 of 579) with videos related to

Sort By:
Pageof 58
British Journal of Cancer|October 1, 1989
Serum C1-esterase inhibitor, an essential and independent prognosticator of gastric carcinomaC W Janssen, R T Lie, H Maartmann-Moe, et al.
Zookeys|November 11, 2016
Revision of the genus <i>Cuvierina</i> Boas, 1886 based on integrative taxonomic data, including the description of a new species from the Pacific Ocean (Gastropoda, Thecosomata)Alice K Burridge, Arie W Janssen, Katja T C A Peijnenburg
Leukemia|July 1, 1993
Mutations within the FLR exon of NF1 are rare in myelodysplastic syndromes and acute myelocytic leukemiasL Ludwig, J W Janssen, A S Schulz, et al.
Oncogene|May 15, 1998
An oncogenic fusion product of the phosphatidylinositol 3-kinase p85beta subunit and HUMORF8, a putative deubiquitinating enzymeJ W Janssen, L Schleithoff, C R Bartram, et al.
British Journal of Cancer|April 1, 1991
The influence of age on the growth and spread of gastric carcinomaC W Janssen, R T Lie, H Maartmann-Moe, et al.
Clinical Chemistry|February 1, 2023
Abdominal Pain and Cola-Colored SerumWouter M Tiel Groenestege, Ella J Wijnen, Marcel J W Janssen
Current Opinion in Urology|November 14, 2023
Restoring the barrier of chronically damaged urothelium using chondroitin sulfate glycosaminoglycan-replenishment therapyBoy B Rozenberg, Charlotte J van Ginkel, Dick A W Janssen
Deutsche Medizinische Wochenschrift (1946)|September 1, 2009
[Update: Preclinical developments for the treatment of pulmonary arterial hypertension]W Janssen, H A Ghofrani, N Weissmann, et al.
Leukemia|March 17, 2000
Tandem duplication of the FLT3 gene in acute lymphoblastic leukemia: a marker for the monitoring of minimal residual diseaseM Nakao, J W Janssen, D Erz, et al.
Blood|June 1, 1988
Mutation of Ki-ras and N-ras oncogenes in myelodysplastic syndromesJ Lyons, J W Janssen, C Bartram, et al.
Pageof 58